Important notification
18.05.2012 To the attention of Marketing Authorisation Holders In the context of implementation of the new pharmacovigilance activity, interested pharmaceutical […]
18.05.2012 To the attention of Marketing Authorisation Holders In the context of implementation of the new pharmacovigilance activity, interested pharmaceutical […]
08.05.2012 To the attention of Marketing Authorisation Holders On the NAMMD website, under the heading “Medicinal products for human use/Pharmacovigilance/Special […]
07.05.2012 To the attention of interested parties Project launch: “NATIONAL E-LEARNING PLATFORM ON PHARMACEUTICAL REGULATION“ – co-financed from the Regional […]
09.03.2012 To the attention of Marketing Authorisation Holders In the context of the implementation of the new pharmacovigilance legislation on […]
09.03.2012 To the attention of interested persons The opinion of the National Agency for Medicines and Medical Devices concerning the […]
27.02.2012 To the attention of interested persons Please be advised that the meeting of the Scientific Council of the National […]
13.01.2012 To the attention of Marketing Authorisation Holders/ Applicants Please be advised that, as of 16.01.2012, the marketing authorisation/MA renewal […]
10.01.2012 To the attention of interested persons In 2011, the National Agency for Medicines and Medical Devices (NAMMD) approved variation […]
10.01.2012 To the attention of interested parties In 2011, the National Agency for Medicines and Medical Devices (NAMMD) approved variation […]
13.12.2011 To the attention of Marketing Authorisation Holders Concerning the procedure for evaluation of IA/IB variations, please be advised that […]